|
1. |
REJECTION OF SPONTANEOUSLY ACCEPTED RAT LIVER ALLOGRAFTS WITH RECIPIENT INTERLEUKIN-2 TREATMENT OR DONOR IRRADIATION1,2 |
|
Transplantation,
Volume 63,
Issue 2,
1997,
Page 177-181
Tu Yizheng,
Arima Takeshi,
Flye3 M.,
Preview
|
|
摘要:
While MHC incompatible DA (RTla) to Lewis (RT11, LEW) rat liver allografts are acutely rejected, the reciprocal LEW to DA liver grafts are spontaneously accepted. The mechanism of this acceptance remains unclear. We evaluated the effect of donor treatment with total body irradiation (TBI) or gadolinium chloride (GdCl3), and recipient treatment with exogenous IL-2 after transplantation on the survival of the spontaneously accepted liver grafts. Male LEW and DA rats were used as donors and recipients for orthotopic liver allo- or iso-graft transplants. The LEW liver donor was treated by TBI (10 gray) 7 days before transplantation, or LEW donor Kupffer cell phagocytosis was blocked with GdCl3(7 mg/kg) on days -2 and -1 pretransplant. In an attempt to reverse LEW liver graft acceptance, 180,000 units human IL-2 (hIL-2) were administered daily IP to the DA liver recipients from days 1 to 7 after liver grafting. While untreated LEW recipients rejected DA liver grafts within 13 days, DA recipients accepted LEW livers indefinitely (>302 days). In contrast, irradiation of the LEW liver donor prevented the spontaneous acceptance by DA recipients, and resulted in acute rejection of the liver grafts in 9-20 days. However, spontaneous graft tolerance was restored by parking the irradiated LEW donor liver in naive LEW rats for 48 hr before retransplantation to DA recipients (>50 days). When LEW donors were treated with GdCl3, which is known to block Kupffer cell phagocytosis and antigen processing, the spontaneous acceptance of the LEW liver grafts by DA recipients was unaffected. However, when exogenous rhIL-2 was given daily, LEW liver allografts were rejected by the DA recipients. The resulting liver failure correlated with a progressive increase in serum bilirubin and the development of a predominantly lymphocytic portal tract infiltration, bile duct epithelial damage, and portal vein endothelitis, which is consistent with acute allograft rejection. LEW and DA recipients of liver isografts developed no toxicity and survived indefinitely (>100 days) when treated with the same dose of IL-2. These results indicate that spontaneous rat liver allograft acceptance is associated with the presence of radiosensitive cells in the donor liver that may interact with recipient T cells to inhibit (Th1) production of IL-2.
ISSN:0041-1337
出版商:OVID
年代:1997
数据来源: OVID
|
2. |
ANTI-GAL IgG ANTIBODIES IN SERA OF NEWBORN HUMANS AND BABOONS AND ITS SIGNIFICANCE IN PIG XENOTRANSPLANTATION1 |
|
Transplantation,
Volume 63,
Issue 2,
1997,
Page 182-186
Minanov2 Oktavijan,
Itescu2 Silviu,
Neethling3 Francisca,
Morgenthau2 Adam,
Kwiatkowski2 Pawel,
Cooper4 D.,
Michler2,5 Robert,
Preview
|
|
摘要:
We have previously demonstrated that hyperacute rejection does not occur in a pig-to-newborn baboon heart transplant model, presumably because of low levels of cytotoxic antipig antibodies present in the serum of newborn baboons. Cytotoxic antipig antibodies are primarily directed to α-1,3-galactosyl (α Gal) residues on endothelial cell surface structures Twenty-one full-term humans and 5 full-term baboons were tested for complement mediated lysis (CML) of pig kidney (PK-15) cells and anti-α Gal activity with an ELISA using BSA-conjugated α Gal residues as target. To evaluate the significance of the anti-α Gal titersin vivo5 newborn baboons underwent heterotopic pig cardiac xenotransplantation. Six of 21 human samples and 1 of 5 baboon samples demonstrated significant cytotoxicity to PK-15 cells. Twelve of 21 newborn humans had anti-α Gal IgG antibodies at titers of 1:80 or greater. None of the samples had anti-α Gal IgM. In newborn baboons, 1 of 5 sera had anti-α Gal IgG antibodies at titers greater than 1:80 and none of these samples had anti-α Gal IgM. Xenografts survived for an average of 3.6 days, even in the baboon with high anti-α Gal IgG titers. Analysis of the explanted grafts showed minimal evidence of complement-mediated hyperacute rejection (HAR), but prominent mononuclear cell infiltrates. In serum tested posttransplant there was an induced anti-α Gal response with cytotoxicity against PK-15 cells. These results show that anti-α Gal IgM is absent in newborn human and baboon sera, allowing pig grafts to avoid HAR. However, the presence of anti-α Gal IgG may be associated with mononuclear cell infiltration of the xenograft and its subsequent rejection.
ISSN:0041-1337
出版商:OVID
年代:1997
数据来源: OVID
|
3. |
THE EFFECT OF SMALL BOWEL TRANSPLANTATION ON THE MORPHOLOGY AND PHYSIOLOGY OF INTESTINAL MUSCLEA Comparison of Autografts Versus Allografts in Dogs1,2 |
|
Transplantation,
Volume 63,
Issue 2,
1997,
Page 186-194
Sugitani Atsushi,
Bauer Anthony,
Reynolds3 James,
Halfter Willi,
Nomoto Minoru,
Starzl Thomas,
Todo Satoru,
Preview
|
|
摘要:
The effects of acute (AR) and chronic rejection (CR) on intestinal smooth muscle that are responsible for the dysmotility following small bowel transplantation (SBTX) are incompletely understood. Jejunal and ileal specimens from normal control dogs (n=7), and autotransplanted dogs were examined at 7 days (n=6) and 1 (n=7), 3 (n=6), 6 (n=6), and 12 months (n=6). Allotransplanted dogs that developed AR (n=8) and CR (n=5) were examined for gross and microscopic morphology (muscle thickness, the number and size of myocytes, and inflammatory infiltrate), and for contractile and intracellular electrical function in vitro. Auto-SBTX did not alter morphology at any period, but contractile function was impaired at 7 days (73.6%) compared with normal intestine. Acute rejection did not influence myocyte number or size, but was associated with a prominent infiltrate of neutrophils and lymphocytes, and severely impaired contractile function (20.6%) compared with auto-SBTX controls. Acute rejection also significantly inhibited the amplitude of slow waves and of inhibitory junction potentials. Chronic rejection caused thickening of muscularis propria by both hyperplasia (175.5%) and hypertrophy (202.6%) accompanied by moderate inflammatory cell infiltrate compared with auto-SBTX controls. We conclude that the marked inflammatory infiltrate into the muscularis propria indicates that the graft muscle is injured by both acute and chronic rejection; impaired function of intestinal smooth muscle following SBTX results from both rejection and the injury associated with transplantation, and chronic rejection following SBTX is associated with both hyperplasia and hypertrophy of the muscularis propria.
ISSN:0041-1337
出版商:OVID
年代:1997
数据来源: OVID
|
4. |
RENOPROTECTIVE EFFECTS OF THE 21-AMINOSTEROID U74389G IN ISCHEMIA-REPERFUSION INJURY AND COLD STORAGE PRESERVATION1,2 |
|
Transplantation,
Volume 63,
Issue 2,
1997,
Page 194-201
Garvin3,4 Paul,
Niehoff5 Michael,
Robinson5 Sandra,
Mistry3 Bhargav,
Esterl3 Robert,
Heisler5 Tracy,
Combs5 Connie,
Berson5 Andrew,
Solomon3 Harvey,
Salinas-Madrigal6 Luis,
Preview
|
|
摘要:
Free radical mediated lipid peroxidation (LPO) has been implicated in the pathogenesis of ischemic-reperfusion injury (IRI). To address the renoprotective effect(s) of LPO inhibition, the efficacy of the 21 aminosteroid U74389G was evaluated in three IRI models. In Model 1 51 unilateral nephrectomized rats that underwent 60 min of warm ischemia followed by a 72-hr reperfusion interval were treated with the test vehicle only, or 3, 6, or 12 mg/kg of U74389G intravenously, 5 min pre- or postischemia. In Model 2 Sprague-Dawley rats underwent sham operation (n=9), or 45 min of warm ischemia and 10 min of reperfusion with U74389G (6 mg/kg; n=10) or test vehicle only (n=10) administered intravenously over 10 min beginning 5 min prior to clamp release. After reperfusion, LPO was determined by assay of snap frozen tissue for thiobarbituric acid (TBA) concentrations (nmol/g tissue weight). In Model 3 domestic lean maid pigs (14-18 kg) underwent left nephrectomy with 30 min of warm ischemia, Collins C-4 flush, and 24 hr of cold storage preservation. Heterotopic autotransplantation and immediate contralateral nephrectomy was then performed in Group A-nonischemic controls (n=4), Group B-ischemic controls (n=5), and Group C-U74389G (6 mg/kg) administered preischemia and at autotransplantation (n=5). In Model 1 maximal renoprotection was demonstrated with the 6 mg/kg dose of U74389G administered after ischemia (ischemic control 72-hr serum creatinine (Cr) = 8.01±1.1 mg% vs. 3.32±0.96 mg%; ischemic control creatinine clearance = 0.069±0.03 ml/min vs. 0.206±0.04 ml/min;P<0.05). In Model 2 TBA levels were significantly lower in U74389G treated animals (88.5±10.0 vs. ischemic controls = 296.8±81.4;P=0.02). In Model 3 graft survivals were 100%, 0%, and 60% respectively. Peak Cr and BUN (mg%) were significantly greater in Group C vs. Group A, (Group A Cr = 8.59±0.63 vs. Group C = 12.8±1.01; Group A BUN = 64.1±2.73 vs. Group C = 104.9±12.21)-however, by day 10, thee were no significant differences in renal function: (Group A Cr = 2.15±0.3 vs. Group C = 2.10±0.06; Group A BUN = 27.0±6.0 vs. Group C = 31.1±6.4). These results support the beneficial effects of LPO inhibitors in models of ischemia-reperfusion, as well as preservation/transplantation, and suggest that this renoprotection correlates with decreased membrane lipid peroxidation.
ISSN:0041-1337
出版商:OVID
年代:1997
数据来源: OVID
|
5. |
COMPARISON OF VARIOUS LAZAROID COMPOUNDS FOR PROTECTION AGAINST ISCHEMIC LIVER INJURY1,2 |
|
Transplantation,
Volume 63,
Issue 2,
1997,
Page 202-208
Ishizaki Naoki,
Zhu Yue,
Zhang Shimin,
Nemoto Akiyoshi,
Kobayashi Yasuyuki,
Subbotin Vladmir,
Starzl Thomas,
Todo3 Satoru,
Preview
|
|
摘要:
Lazaroids are a group of 21-aminosteroids that lack steroid action but have a potent cytoprotective effect by inhibiting iron-dependent lipid peroxidation. However, there have been conflicting reports on the effectiveness and potency of the various lazaroid compounds. In this study, we compared the effectiveness of three major lazaroids on warm liver ischemia in dogs using a 2-hr hepatic vascular exclusion model. The agents were given to the animals intravenously for 30 min before ischemia. The animals were divided into 5 groups: Control (n=10), no treatment; Group F (n=6), U-74006F (10 mg/kg); Group G (n=6), U-74389G (10 mg/kg); Group A1 (n=6), U-74500A (10 mg/kg); Group A2 (n=6), U-74500A (5 mg/kg). The effect of treatment was evaluated by two-week animal survival, hepatic tissue blood flow, liver function tests, blood and tissue biochemistry, and histological analyses. Animal survival in all treated groups was significantly improved compared with the control (83-100% versus 30%). Elevation of liver enzymes after reperfusion was markedly attenuated in treated groups, except for an early significant increase in Group G. Postreperfusion hepatic tissue blood flow was much higher in all treated animals (50% of the preischemic level vs. 25% in the control). Lazaroids, particularly U-74500A at 5 mg/kg (Group A2), suppressed adenine nucleotide degradation during ischemia and enhanced the resynthesis of high-energy phosphates after reperfusion. Although structural abnormalities in postreperfusion liver tissues were markedly ameliorated in all treated groups, Group A2 showed significantly less neutrophil infiltration. Liver injury from warm ischemia and reperfusion was attenuated with all lazaroid compounds, of which U-74500A at 5 mg/kg exhibited the most significant protective activity.
ISSN:0041-1337
出版商:OVID
年代:1997
数据来源: OVID
|
6. |
RIGHT VENTRICULAR FAILURE-INSIGHTS PROVIDED BY A NEW MODEL OF CHRONIC PULMONARY HYPERTENSION1 |
|
Transplantation,
Volume 63,
Issue 2,
1997,
Page 209-216
Chen2,3,4 Edward,
Bittner4 Hartmuth,
Davis4 R.,
Van Trigt4 Peter,
Preview
|
|
摘要:
This study was designed to examine the effects of both nitric oxide and milrinone on pulmonary hemodynamics and right ventricular function using a newly established model of monocrotaline pyrrole-induced chronic pulmonary hypertension. Sixteen mongrel dogs (23-25 kg) were used. All animals underwent percutanous pulmonary artery catheterization to measure right heart hemodynamics prior to and 8 weeks after a right atrial injection of either monocrotaline pyrrole (MCTP, n=8) or placebo (CTL, n=8). Eight weeks postinjection, all hearts were instrumented with a pulmonary artery flow probe and intracavitary micromanometers. Data were collected at baseline as well as following both nitric oxide and milrinone administration. There was no significant difference in the baseline hemodynamic measurements between the two groups. Eight weeks postinjection, significant increases in the pulmonary artery pressure and pulmonary vascular resistance were observed in MCTP compared with CTL. Both nitric oxide and milrinone resulted in significant improvements in pulmonary vascular resistance, pulmonary blood flow, and right ventricular contractility. In addition, nitric oxide caused a significant improvement in pulmonary artery pressure and transpulmonary efficiency, while milrinone led to a significant increase in right ventricular hydraulic power. This study demonstrates the well-known clinical effects of nitric oxide and milrinone in improving pulmonary hypertension, which were also associated with an increase in pulmonary blood flow, transpulmonary efficiency, and right ventricular hydraulic power in the setting of monocrotaline pyrrole-induced chronic pulmonary hypertension.
ISSN:0041-1337
出版商:OVID
年代:1997
数据来源: OVID
|
7. |
ATTENUATION OF ISCHEMIC LIVER INJURY BY AUGMENTATION OF ENDOGENOUS ADENOSINE1,2 |
|
Transplantation,
Volume 63,
Issue 2,
1997,
Page 217-223
Todo3 Satoru,
Zhu Yue,
Zhang Shimin,
Jin Maeng,
Ishizaki Naoki,
Tanaka Hiromu,
Subbotin Vladimir,
Starzl Thomas,
Preview
|
|
摘要:
Hepatic grafts from non-heartbeating donors may alleviate the organ shortage, but they inherently suffer from warm ischemia. In the present study, we tested our hypothesis that augmentation of endogenous adenosine by inhibition of nucleoside transport with R75231 attenuates ischemic liver injury. Adult female beagle dogs underwent 2-hr hepatic vascular exclusion with venovenous bypass. R75231 was given to the animals by continuous intravenous infusion for 30 min before ischemia at a dose of 0.1 mg/kg (Group 2, n=6), 0.05 mg/kg (Group 3, n=6), or 0.025 mg/kg (Group 4, n=6). Nontreated animals were used as the control (Group 1, n=10). Animal survival, hepatic tissue blood flow, liver function, and histopathology were analyzed. Two-week animal survival was 30% in Group 1, 83% in Group 2, 100% in Group 3, and 100% in Group 4. Postreperfusion hepatic tissue blood flow was markedly improved by the treatment. Treatment significantly attenuated liver enzyme release, lipid peroxidation, and changes in adenine nucleotides and purine catabolites. Structural abnormality of the liver after reperfusion was markedly improved by R75231 treatment, showing better architecture and less neutrophil infiltration. Preischemic administration of a nucleoside transport inhibitor ameliorated ischemic liver injury due to the positive effects of augmented endogenous adenosine, and is applicable clinically when the liver is procured from a controlled non-heartbeating donor.
ISSN:0041-1337
出版商:OVID
年代:1997
数据来源: OVID
|
8. |
TACROLIMUS RESCUE THERAPY FOR RENAL ALLOGRAFT REJECTION-FIVE-YEAR EXPERIENCE1 |
|
Transplantation,
Volume 63,
Issue 2,
1997,
Page 223-228
Jordan2,3 Mark,
Naraghi3 Robert,
Shapiro4 Ron,
Smith3,5 Deidre,
Vivas3 Carlos,
Scantlebury4 Velma,
Gritsch3 H.,
McCauley4 Jerry,
Randhawa4 Parmjeet,
Demetris4 Anthony,
McMichael4 John,
Fung4 John,
Starzl4 Thomas,
Preview
|
|
摘要:
Over the 5 year period from 7/14/1989 until 5/24/1994, we have attempted graft salvage with tacrolimus conversion in a total of 169 patients (median age 33 years, range 2-75 years) with ongoing rejection on baseline CsA immunosuppression after failure of high dose corticosteroids and/or antilymphocyte preparations to reverse rejection. The indications for conversion to tacrolimus were ongoing, biopsy confirmed rejection in all patients. The median interval to tacrolimus conversion was 2 months (range 2 days to 55 months; mean 4.3±2.6 months) after transplantation. All patients had failed high dose corticosteroid therapy and 144 (85%) of the 169 patients had received at least one course of an antilymphocyte preparation plus high dose corticosteroid therapy prior to conversion. Twenty-eight patients (17%) were dialysis-dependent at the time of conversion owing to the severity of rejection. With a mean follow-up of 30.0±2.4 months (median 36.5 months, range 12-62 months), 125 of 169 patients (74%) have been successfully rescued and still have functioning grafts with a mean serum creatinine (SCR) of 2.3± 1.1 mg/dl. Of the 144 patients previously treated with antilymphocyte preparations, 117 (81%) were salvaged. Of the 28 patients on dialysis at the time of conversion to tacrolimus, 13 (46%) continue to have functioning grafts (mean SCR 2.15±0.37 mg/dl) at a mean follow-up of 37.3± 16.7 months. In the 125 patients salvaged, prednisone doses have been lowered from 28.0±9.0 mg/d (median 32, range 4-60 mg/d) preconversion to 8.5±4.1 mg/d (median 12 mg/d, range 2.5-20 mg/d) postconversion. Twenty-eight patients (22.4%) are currently receiving no steroids. This 5 year experience demonstrates that tacrolimus has sustained efficacy as a rescue agent for ongoing renal allograft rejection. Based on these data, we recommend that tacrolimus be used as an alternative to the conventional drugs used for antirejection therapy in renal transplantation.
ISSN:0041-1337
出版商:OVID
年代:1997
数据来源: OVID
|
9. |
LAPAROSCOPIC ASSISTED LIVE DONOR NEPHRECTOMY - A COMPARISON WITH THE OPEN APPROACH1 |
|
Transplantation,
Volume 63,
Issue 2,
1997,
Page 229-233
Ratner2 Lloyd,
Kavoussi3 Louis,
Sroka4 Myrna,
Hiller4 Janet,
Weber4 Rebecca,
Schulam3 Peter,
Montgomery4 Robert,
Preview
|
|
摘要:
Live donor renal transplantation provides significant advantages when compared with cadaveric donor renal transplantation in terms of improved patient and graft survival, a lower incidence of delayed function, and a shorter waiting time. Yet despite these advantages, live donors continue to be an under utilized source of kidneys for transplantation. Disincentives to live donation include the length of hospitalization, postoperative pain, cosmetic concerns, and the prolonged convalescence associated with the donor operation. In many instances minimally invasive video-assisted techniques have proven more efficacious than standard open procedures in terms of patient discomfort, length of hospital stay, cost, and length of time until the patient can return to full activity. Laparoscopic live donor nephrectomies are being performed at our institution in an attempt to make live donation more attractive to the potential donor. The purpose of this study was to retrospectively review the results of laparoscopic live donor nephrectomy (LapNx) and to compare them with those obtained using the standard open approach (OpenNx). Ten consecutive LapNx were performed from February 1995 through April 1996. The control group consisted of the 20 consecutive OpenNx performed at the same institution from January 1991 through January 1995 immediately before the initiation of the LapNx program. Live donors were considered candidates for LapNx if they possessed at least one kidney with normal renal anatomy with single renal vessels and a single ureter. LapNx was safely performed in all cases. No patients required open conversion or blood transfusions. The allograft warm ischemic time for the laparoscopic cases was 4.2±1.3 min. All kidneys harvested laparoscopically produced urine on the table immediately upon revascularization. Presently nine of the ten recipients have functioning allografts. At three months posttransplant the calculated recipient creatinine clearances were 67.0±11.5 ml/min and 64.8±21.4 ml/min for the LapNx and OpenNx groups, respectively (P=NS). The LapNx donors had a significantly decreased estimated blood loss, shorter time until resumption of oral intake, decreased postoperative pain (in terms of decreased analgesic requirements), shorter hospitalization, and a shorter interval until the resumption of full activities (P<0.05 for all). In addition, the LapNx group donors returned to work sooner than the OpenNx group (3.9±1.6 wk vs. 6.4±3.1 wk, respectively) (P=0.024). Four individuals agreed to donate a kidney only after learning of the availability of the laparoscopic approach. We conclude that laparoscopic live donor nephrectomy is technically feasible. In addition, it may offer significant advantages over the standard open approach in terms of patient comfort and convenience. These advantages may make live donor renal transplantation more attractive to prospective donors. The potential decrease in hospitalization and convalescence may also prove to be financially advantageous. We believe that further careful study of this procedure is warranted.
ISSN:0041-1337
出版商:OVID
年代:1997
数据来源: OVID
|
10. |
IMMUNOLOGIC AND PATIENT SELECTION STRATEGIES FOR SUCCESSFUL UTILIZATION OF LESS THAN 15 KG PEDIATRIC DONOR KIDNEYS-LONG TERM EXPERIENCES WITH 40 TRANSPLANTS1 |
|
Transplantation,
Volume 63,
Issue 2,
1997,
Page 233-237
Bretan2,3,4 Peter,
Friese2,4 Christopher,
Goldstein5 Ruth,
Osorio2,4 Robert,
Tomlanovich4,6 Stephen,
Amend4,6 William,
Mathur4,6 Vandana,
Vincenti4,6 Flavio,
Preview
|
|
摘要:
Renal transplantation using infant donors is associated with significantly less graft survival (GS) and increased morbidity, especially from very young and small donors. We report our results using specific strategies to determine which age and size donor require en bloc renal transplant reconstruction and associated immunologic protocols for optimization of subsequent GS. Forty cadaveric pediatric en bloc renal transplants were performed. Mean donor age was 23.6±18.4 months with subgroups: 2-12 months, n=14; 13-24 months, n=19; and 25-60 months, n=7. Mean donor weight was 14.4±4.5 kg. All kidneys were placed in primary, nonsensitized (peak PRA = 7.9±5.6%) adult (41.6±16 years) recipients. Low weight was preferred (62.4±12.8 kg). Mean cold ischemia time was 26.9±8.6 hr. Immunosuppression consisted of quadruple immunosuppression (QI) with OKT3 induction. All patients had ureteral stents placed intraoperatively. Mean follow-up was 16.9 months. Actuarial GS at 12, 24, and 33 months were 100% (n=13), 85% (n=20), and 71% (n=7), respectively. Total GS was 35/40=88%. All grafts functioned immediately and there were no technical losses. Biopsy proven rejections occurred in 12 (30%) patients, developing at 16-167 days postoperatively (mean = 50.3 days). Mean serum creatinine at one week and 1, 6, 12, and 18 months were 2.1±2.0, 1.5±0.8, 1.3±0.5, 1.1±0.4, and 0.9±0.4 mg/dl, respectively. Functional isotopic renography, as well as sonographic monitoring reflected rapid initial and continued growth in these kidneys. Mean BP at 12 and 24 months postoperatively were 145/83±18/13 and 122/76±20/10 mmHg, respectively, with no significant proteinuria noted. Excellent results with minimal complications utilizing very small and young infant donors can be achieved with QI immunosuppression, and selection of low immune reactive and noncomplicated adult recipients. Additionally, maximal renal dosing by minimizing recipient weight may prevent future hyperfiltration damage.
ISSN:0041-1337
出版商:OVID
年代:1997
数据来源: OVID
|
|